📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Identification of te RNA targets of the TIS11b and d tumour suppressors

Lead Research Organisation: Babraham Institute
Department Name: UNLISTED

Abstract

Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.

Technical Summary

The control of mRNA stability and translation is widely used by cells to control proliferation, differentiation and apoptosis. The importance of post-transcriptional control is underscored by observations that it is deregulated in malignant diseases including leukaemia and lymphoma. However, our understanding of post-transcriptional control mechanisms, and their relevance to cancer, lags far behind our understanding of transcriptional regulation and signal transduction. Post transcriptional control is an area of investigation that has been relatively neglected in the search for an understanding of oncogenic mechanisms and novel routes to therapy. This proposal seeks to further our understanding of how RNA binding proteins (RBP) regulate fundamental cellular processes and how they are integrated with signaling and transcriptional processes which may be corrupted in cancer.

Planned Impact

unavailable
 
Description mechanisms controlling cell division. We alos discoverd thta RNA binding proteins control cellular identity amongst B cells. In a collaborative study we found that ZFP36L2 was important for limiting IFNg production by T cells. We also found the RBP were essential in muscle stem cell development and or function. see the published papers for details.

also

http://www.babraham.ac.uk/news/2016/04/quiescence-B-cells and a novel mechanism of epigentic control of the Marginal zone B cell
Exploitation Route anti-cancer therapy
Sectors Healthcare

Pharmaceuticals and Medical Biotechnology

URL http://www.babraham.ac.uk/news/2016/04/quiescence-B-cells
 
Description Interest in our work has led to the development of a collaboration with Cancer Research Technology and Celgene. This has now been funded
Sector Healthcare,Pharmaceuticals and Medical Biotechnology
Impact Types Economic

 
Description Investigator Award
Amount £1,300,000 (GBP)
Organisation Wellcome Trust 
Sector Charity/Non Profit
Country United Kingdom
Start 03/2017 
End 03/2022